Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersOperating ExpensesProfit After TaxSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Green Planet Bio Engineering (GPLB) EBITDA (2016 - 2026)

Green Planet Bio Engineering's EBITDA history spans 16 years, with the latest figure at -$10794.0 for Q1 2026.

  • On a quarterly basis, EBITDA fell 57.81% to -$10794.0 in Q1 2026 year-over-year; TTM through Mar 2026 was -$39796.0, a 10.79% decrease, with the full-year FY2025 number at -$9319.0, down 0.84% from a year prior.
  • EBITDA came in at -$10794.0 for Q1 2026, up from -$16298.0 in the prior quarter.
  • The five-year high for EBITDA was -$4105.0 in Q2 2025, with the low at -$17840.0 in Q1 2023.
  • Historically, EBITDA has averaged -$9671.6 across 5 years, with a median of -$8563.5 in 2023.
  • Biggest five-year swings in EBITDA: surged 63.76% in 2024 and later plummeted 58.51% in 2025.
  • Year by year, EBITDA stood at -$5788.0 in 2022, then crashed by 134.11% to -$13550.0 in 2023, then grew by 5.6% to -$12791.0 in 2024, then fell by 27.42% to -$16298.0 in 2025, then soared by 33.77% to -$10794.0 in 2026.
  • Business Quant data shows EBITDA for GPLB at -$10794.0 in Q1 2026, -$16298.0 in Q4 2025, and -$8599.0 in Q3 2025.